The physical and emotional challenges of chronic skin diseases are devastating to patients, particularly children. ResVita Bio seeks to restore and maintain the vitality of the skin through engineered skin probiotics. Through synthetic biology and metabolic engineering, we are developing a safe and versatile skin microbial platform that continuously deliver therapies that address the causes of chronic skin diseases. 

ResVita Bio is developing a rich product pipeline to treat inflammatory skin diseases like Netherton Syndrome, atopic dermatitis, psoriasis, acne, and rosacea. 

Biotechnology

Health Care

Life Sciences

Therapeutics

ResVita Bio

Org chart

Similar companies